PDA

View Full Version : FOXC2 Vital To Epithelial-Mesenchymal Transition In Breast Cancer; FDA-Approved Drug


News
02-15-2013, 03:21 AM
Protein central to cancer stem cell formation provides new potential target Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development...

More... (http://www.medicalnewstoday.com/releases/256377.php)